≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other and unspecified nonscarring hair loss

DOID EFO Endpoint Browser PheWeb

L12_HAIRLOSS_NONSCARNAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

247

4. Check minimum number of events

None

247

5. Include endpoints

None

247

6. Filter based on genotype QC (FinnGen only)

247

Control definitions (FinnGen only)

Control exclude
L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1676 1527 142
Only index persons 1591 1465 126
Unadjusted period prevalence (%)
Whole population 0.04 0.04 0.00
Only index persons 0.05 0.05 0.00
Median age at first event (years)
Whole population 38.60 40.48 18.66
Only index persons 39.71 41.33 20.91

-FinnGen-

Key figures

All Female Male
Number of individuals 247 242 5
Unadjusted period prevalence (%) 0.08 0.08 0.00
Median age at first event (years) 45.95 46.30 28.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
212
Matched controls
2118
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L65.9
ICD-10 Finland
Nonscarring hair loss, unspecified
2824.3
192.8
157
*
L65.8
ICD-10 Finland
Other specified nonscarring hair loss
904.4
69.1
64
*
C03DA01
ATC
spironolactone; oral
12.0
33.4
65
75
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.2
20.1
47
71
L64.9
ICD-10 Finland
Androgenic alopecia, unspecified
+∞
18.0
17
*
L63.9
ICD-10 Finland
Alopecia areata, unspecified
69.2
17.0
19
*
D07AC13
ATC
mometasone; topical
3.7
16.9
99
406
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.2
12.7
81
339
D07AB02
ATC
hydrocortisone butyrate; topical
3.1
12.3
88
396
D07AC01
ATC
betamethasone; topical
3.0
12.3
98
473
L63.8
ICD-10 Finland
Other alopecia areata
+∞
11.6
11
*
J01AA04
ATC
lymecycline; systemic
3.7
11.3
53
173
D07AD01
ATC
clobetasol; topical
3.5
10.0
51
177
E0000UV
ATC
NA
2.4
8.4
110
660
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.3
8.0
98
569
L65.0
ICD-10 Finland
Telogen effluvium
46.7
7.8
9
*
S23
ICPC
Hair loss/baldness
16.5
7.3
11
7
L65
ICD-10 Finland
Other nonscarring hair loss
31.2
7.2
9
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
12.6
7.2
12
10
D07XC01
ATC
betamethasone, combinations; topical
3.8
7.1
30
89
H03AA01
ATC
levothyroxine sodium; systemic
2.4
7.0
73
384
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.6
7.0
57
265
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.5
7.0
24
59
H04.10
ICD-10 Finland
Dry eye syndrome
3.3
6.9
35
120
D10AX03
ATC
azelaic acid; topical
3.3
6.6
33
112
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
3.5
6.6
30
95
L70.0
ICD-10 Finland
Acne vulgaris
8.6
6.4
13
16
L68.0
ICD-10 Finland
Hirsutism
+∞
6.3
6
*
A06AC01
ATC
ispaghula (psylla seeds); oral
2.3
6.0
60
307

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
35
77
5.13
15.49
1.2
1.2
—
—
—
0
0
132
739
2.69
13.13
2.2
1.8
100.8
98.0
pmol/l
0.23
75
361
131
747
2.60
12.32
6.0
3.9
36.6
36.6
g/l
0.05
123
698
166
1088
2.60
11.27
6.5
5.1
1.9
2.0
e9/l
0.35
156
966
165
1081
2.59
11.16
6.8
5.5
0.2
0.2
e9/l
0.44
156
957
117
655
2.49
11.14
6.7
5.0
—
—
—
0
0
71
312
2.79
11.11
1.5
1.4
615.2
558.2
titre
0.11
21
68
161
1046
2.55
11.04
6.7
5.2
0.0
0.0
e9/l
0.30
149
901
160
1040
2.53
10.90
6.7
5.2
0.5
0.5
e9/l
0.28
149
901
168
1131
2.52
10.39
3.7
2.7
98.1
65.3
ug/l
1.83
161
1053
142
891
2.40
10.22
8.5
5.1
1.2
1.2
mmol/l
0.19
127
745
106
596
2.36
9.68
1.5
1.2
2.2
1.4
u/ml
0.26
25
156
225
1785
3.92
9.68
6.1
4.4
14.6
14.4
pmol/l
0.50
215
1645
149
979
2.32
9.31
7.5
5.5
8.1
8.1
%
0.01
144
908
97
535
2.34
9.16
1.6
1.3
2.1
2.1
g/l
0.06
63
321
148
974
2.30
9.16
7.1
5.2
2.8
2.6
%
0.53
143
898
22
51
4.64
9.07
1.1
1.3
98.0
58.0
titre
—
5
5
143
933
2.27
8.97
7.2
5.3
0.7
0.7
%
0.15
138
856
151
1012
2.27
8.81
6.8
5.0
56.4
56.4
%
0.01
144
940
127
797
2.22
8.67
7.3
4.6
1.2
1.2
mmol/l
0.75
116
724
151
1019
2.24
8.57
7.2
5.2
29.7
29.8
%
0.06
145
943
111
678
2.16
7.92
4.0
2.8
2.4
2.4
mmol/l
0.13
99
599
43
177
2.73
7.43
6.1
4.6
1.1
1.0
mmol/l
0.15
38
163
65
329
2.32
7.26
2.8
2.1
84.0
112.3
ug/g
0.50
49
245
164
1194
2.11
7.04
10.1
8.1
3.7
3.9
e9/l
0.63
153
1043
28
93
3.27
7.03
2.5
2.1
—
—
—
0
0
199
1572
2.37
6.83
6.0
3.8
10.7
10.0
mm/h
0.32
191
1439
45
198
2.56
6.80
2.0
1.8
404.3
389.3
nmol/l
0.18
39
184
55
274
2.30
6.31
1.3
1.2
—
—
—
0
0
59
306
2.22
6.14
6.3
3.1
573.2
173.0
ng/l
0.34
38
193
62
334
2.14
5.85
2.8
2.3
2.4
2.4
mmol/l
0.40
55
289
45
212
2.37
5.84
3.7
2.1
24.7
23.7
%
0.17
40
183
38
166
2.52
5.80
5.7
3.9
—
—
—
0
0
147
1072
1.92
5.77
4.8
3.9
6.4
6.3
mmol/l
0.31
137
951
48
234
2.30
5.76
3.4
2.0
2.2
2.4
g/l
2.36
48
216
188
1495
2.08
5.67
6.6
4.0
—
—
—
0
0
50
250
2.25
5.65
2.0
1.9
—
—
—
0
0
18
52
3.66
5.57
1.7
2.2
1.5
1.4
g/l
0.22
18
41
234
2053
3.66
5.54
7.4
5.1
1.7
2.3
mu/l
0.59
227
1914
81
492
1.96
5.47
2.7
1.9
2.5
2.9
mg/l
0.83
69
409
128
904
1.86
5.44
2.5
2.0
—
—
—
0
0
54
284
2.15
5.38
1.7
1.6
1210.1
1162.8
nmol/l
0.17
44
209
12
26
4.80
5.32
1.7
1.2
—
—
—
0
0
66
378
2.02
5.24
3.7
3.4
—
—
—
0
0
85
533
1.91
5.18
2.6
2.0
109.1
142.6
u/l
0.95
77
507
80
493
1.92
5.13
3.1
3.2
—
—
—
0
0
45
225
2.22
5.07
1.4
1.3
—
—
—
0
0
188
1528
1.96
4.88
10.7
6.4
74.2
74.7
u/l
0.06
182
1423
94
621
1.83
4.81
4.7
5.9
1.1
1.1
inr
0.10
28
209
95
638
1.79
4.55
3.3
2.6
—
—
—
0
0
42
214
2.16
4.50
1.1
1.3
39.3
194.5
iu/ml
5.39
16
93
86
563
1.81
4.47
5.0
3.3
7.4
7.4
ph
0.35
14
108
69
424
1.87
4.39
1.8
1.4
21.9
21.7
nmol/l
0.03
61
357
62
369
1.91
4.34
1.9
1.6
448.8
453.7
pmol/l
0.05
55
318
115
830
1.72
4.21
4.2
3.0
—
—
—
0
0
21
83
2.67
3.91
1.7
1.7
—
—
—
0
0
39
204
2.08
3.91
1.3
1.1
—
—
—
0
0
11
30
3.79
3.68
1.5
1.1
—
—
—
0
0
18
69
2.74
3.56
1.2
1.2
7.6
12.6
u/l
1.07
12
58
91
641
1.66
3.50
2.5
2.0
—
—
—
0
0
52
313
1.84
3.47
1.6
1.5
—
—
—
0
0
27
128
2.25
3.45
1.3
1.3
—
—
—
0
0
77
522
1.69
3.41
4.1
4.1
—
—
—
0
0
6
7
8.75
3.28
1.0
1.0
142.5
134.1
nmol/l
—
6
7
66
434
1.71
3.25
1.5
1.3
14.5
31.5
iu/ml
1.87
17
144
40
226
1.92
3.23
3.1
2.4
4.3
4.9
umol/l
0.35
32
192
40
230
1.88
3.07
1.5
1.3
—
—
—
0
0
6
8
7.65
3.07
1.7
1.1
—
—
—
0
0
38
215
1.91
3.06
1.8
1.4
—
—
—
0
0
133
1058
1.56
2.95
4.6
3.2
0.0
0.0
estimate
0.00
27
213
78
549
1.61
2.93
4.1
2.9
149.5
40.0
e6/l
0.54
62
411
131
1040
1.55
2.92
4.4
3.8
—
—
—
0
0
203
1791
1.75
2.87
6.3
4.7
38.2
38.0
mmol/mol
0.08
192
1681
28
147
2.02
2.79
1.3
1.2
—
—
—
0
0
7
14
5.11
2.74
1.4
1.9
—
—
—
0
0
85
621
1.56
2.70
3.2
3.0
16.3
37.3
ng/l
0.88
48
332
7
15
4.77
2.61
1.4
3.1
—
—
—
0
0
65
449
1.61
2.61
2.0
1.7
—
—
—
0
0
24
122
2.07
2.61
4.6
3.4
—
—
—
0
0
131
1058
1.51
2.59
6.3
4.4
0.0
0.0
estimate
0.50
27
217
12
44
2.82
2.58
1.3
1.3
—
—
—
0
0
27
144
1.98
2.58
2.1
4.3
0.3
0.7
%
—
9
26
5
7
7.26
2.56
1.6
1.3
—
—
—
0
0
221
2020
1.89
2.49
5.1
4.2
2.8
2.9
mmol/l
0.64
206
1871
7
16
4.47
2.49
1.1
1.4
—
—
—
0
0
93
704
1.51
2.48
5.1
3.3
184.5
49.0
e6/l
0.78
67
455
220
2011
1.86
2.43
4.6
3.8
4.8
4.8
mmol/l
0.52
208
1879
11
40
2.83
2.41
3.6
3.0
4.0
4.2
e9/l
0.17
11
40
11
40
2.83
2.41
3.6
3.4
59.4
59.0
%
0.03
11
40
5
8
6.35
2.38
1.2
1.5
—
—
—
0
0
28
156
1.90
2.37
2.4
4.4
0.7
0.8
%
—
10
39
131
1071
1.48
2.36
4.7
3.2
0.0
0.0
estimate
0.00
27
210
66
469
1.56
2.33
2.0
1.7
1.0
0.8
mg/l
0.26
45
347
9
28
3.30
2.33
1.0
1.1
—
—
—
0
0
10
36
2.85
2.23
2.9
2.8
—
—
—
0
0
65
467
1.53
2.18
4.4
3.2
—
—
—
0
0
26
146
1.87
2.16
2.3
4.6
0.1
0.0
%
—
10
33
70
513
1.51
2.14
4.3
2.6
—
—
—
0
0
71
522
1.51
2.13
4.0
2.8
7.6
7.4
mmol/l
0.08
58
439
71
523
1.50
2.11
7.9
6.8
—
—
—
0
0
228
2126
1.94
2.09
19.4
10.7
14.6
18.8
mg/l
1.73
181
1603
13
56
2.39
2.08
1.3
1.3
327.2
330.3
ug/g
—
8
30
40
259
1.65
2.06
1.3
1.2
—
—
—
0
0
19
97
2.04
2.06
1.2
1.3
—
—
—
0
0
61
438
1.52
2.04
4.3
3.1
1092.5
392.0
mg/l
0.32
39
249
117
955
1.43
2.03
8.9
7.9
0.0
0.0
e9/l
0.79
101
780
9
32
2.88
2.02
1.4
1.4
—
—
—
0
0
7
21
3.40
1.98
4.9
2.7
—
—
—
0
0
154
1326
1.43
1.96
4.0
3.1
—
—
—
0
0
8
27
3.03
1.95
1.3
6.0
—
—
—
0
0
84
649
1.45
1.95
2.4
2.0
—
—
—
0
0
9
33
2.79
1.95
1.3
1.9
—
—
—
0
0
6
16
3.82
1.94
4.8
2.2
56.2
51.3
%
—
6
16
208
1903
1.59
1.91
4.2
3.4
1.2
1.2
mmol/l
0.48
196
1764
214
1975
1.63
1.84
4.8
3.8
5.8
5.7
mmol/l
0.88
200
1825
19
102
1.93
1.82
10.6
6.8
—
—
—
0
0
7
23
3.10
1.81
1.1
1.9
—
—
—
0
0
7
23
3.10
1.81
1.4
4.1
19.3
30.7
umol/l
—
7
16
9
36
2.56
1.76
1.4
1.2
—
—
—
0
0
215
1992
1.61
1.75
4.7
3.8
1.6
1.6
mmol/l
0.16
202
1855
13
61
2.19
1.75
4.2
3.0
0.2
0.2
g/l
—
5
20
236
2245
2.15
1.74
16.5
9.9
—
—
—
0
0
24
142
1.76
1.72
2.4
4.6
0.0
0.0
%
—
9
28
8
31
2.63
1.67
1.0
1.1
—
—
—
0
0
61
456
1.45
1.66
5.5
3.7
36.6
10.7
mg/mmol
0.40
39
251
66
504
1.42
1.60
4.5
2.7
0.1
0.4
e6/l
2.50
50
370
5
15
3.38
1.53
1.6
2.3
—
—
—
0
0
58
437
1.43
1.51
1.5
1.3
11.1
14.3
u/ml
0.11
21
173
58
438
1.42
1.49
3.2
2.5
308.8
6294.6
umol/l
2.29
52
391
9
37
2.49
1.49
1.4
1.4
—
—
—
0
0
5
16
3.17
1.44
1.6
1.1
—
—
—
0
0
6
22
2.77
1.44
1.7
1.2
—
—
—
0
0
9
40
2.30
1.41
5.3
2.6
1.3
1.3
mg/l
—
9
34
29
193
1.57
1.37
1.4
1.4
—
—
—
0
0
69
547
1.36
1.33
1.8
1.7
—
—
—
0
0
9
43
2.13
1.31
1.2
1.2
—
—
—
0
0
6
24
2.54
1.31
2.0
2.2
—
—
—
0
0
26
171
1.58
1.29
1.4
1.4
—
—
—
0
0
21
132
1.65
1.25
4.0
3.2
—
—
—
0
0
17
101
1.73
1.23
2.1
2.3
60.9
72.0
e9/l
0.94
12
77
25
166
1.56
1.20
5.6
15.8
1.1
1.3
inr
—
10
28
6
26
2.34
1.19
1.3
1.2
—
—
—
0
0
6
26
2.34
1.19
1.2
1.0
—
—
—
0
0
6
26
2.34
1.19
1.0
1.0
—
—
—
0
0
15
89
1.73
1.10
1.3
2.3
—
—
—
0
0
25
171
1.51
1.07
3.2
4.0
3.0
5.2
ug/l
0.88
14
136
5
22
2.30
1.04
1.0
1.4
—
—
—
0
0
20
131
1.57
1.03
1.2
1.8
—
—
—
0
0
5
23
2.20
0.98
2.4
2.0
—
—
—
0
0
13
77
1.73
0.97
5.4
4.0
—
—
—
0
0
0
32
0.00
0.96
0.0
1.6
—
23754.7
—
0
21
6
27
2.25
0.94
1.3
1.2
—
—
—
0
0
20
138
1.49
0.84
1.2
1.8
—
—
—
0
0
20
138
1.49
0.84
1.2
1.8
—
—
—
0
0
20
139
1.48
0.82
1.2
1.7
—
—
—
0
0
8
47
1.73
0.81
1.8
2.8
—
—
—
0
0
57
474
1.26
0.78
3.9
3.2
1.0
1.0
kg/l
—
6
74
20
142
1.44
0.75
1.3
1.1
—
—
—
0
0
7
38
1.87
0.74
1.4
1.3
—
—
—
0
0
9
57
1.60
0.72
1.6
1.2
421.7
347.4
mg/l
—
9
51
26
196
1.36
0.71
6.0
3.3
—
—
—
0
0
13
85
1.56
0.70
3.8
2.6
—
—
—
0
0
9
59
1.54
0.69
1.9
1.7
—
—
—
0
0
9
59
1.54
0.69
4.2
2.3
0.9
1.2
%
—
9
59
65
559
1.22
0.66
5.6
3.5
0.0
0.0
estimate
0.80
27
215
7
44
1.61
0.65
2.4
1.1
—
—
—
0
0
19
138
1.41
0.64
1.2
1.7
—
—
—
0
0
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
11
72
1.55
0.60
3.5
1.9
20.2
20.9
s
—
6
61
8
52
1.56
0.60
10.4
4.4
1.6
1.2
mmol/l
—
8
44
8
52
1.56
0.60
1.3
1.1
4.8
2.3
e6/l
—
8
43
8
52
1.56
0.60
1.3
1.2
14.1
76.7
e6/l
—
8
46
6
38
1.59
0.54
5.0
3.6
—
—
—
0
0
9
63
1.44
0.53
10.2
3.2
—
—
—
0
0
17
128
1.35
0.49
1.1
1.1
—
—
—
0
0
7
47
1.50
0.48
2.1
2.6
—
—
—
0
0
7
49
1.44
0.46
2.0
1.8
—
—
—
0
0
24
193
1.27
0.45
3.6
2.2
144.1
6028.3
u/l
—
9
79
12
87
1.40
0.43
1.2
1.1
—
—
—
0
0
8
57
1.42
0.42
4.0
2.3
0.6
0.7
%
—
8
57
10
70
1.45
0.42
17.9
6.7
—
—
—
0
0
5
33
1.53
0.41
2.4
1.6
—
—
—
0
0
37
317
1.20
0.41
1.8
1.9
—
—
—
0
0
69
626
1.14
0.38
4.3
2.8
—
—
—
0
0
6
46
1.31
0.33
1.5
1.1
—
—
—
0
0
21
175
1.22
0.31
2.0
1.7
—
—
—
0
0
12
93
1.31
0.30
1.5
2.2
—
—
—
0
0
12
95
1.28
0.27
1.8
1.6
—
—
—
0
0
77
719
1.10
0.26
1.7
1.6
—
—
—
0
0
9
77
1.18
0.24
12.9
7.1
91.6
94.6
%
—
9
77
205
2009
1.12
0.24
19.4
11.6
40.0
39.7
%
0.65
156
1581
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
29.0
—
0
7
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
121.0
—
0
14
21
184
1.15
0.20
1.4
1.4
—
—
—
0
0
15
128
1.18
0.18
1.6
1.4
—
—
—
0
0
15
129
1.17
0.17
1.6
1.4
—
—
—
0
0
8
70
1.15
0.16
1.0
1.1
—
—
—
0
0
8
73
1.10
0.16
1.0
1.2
—
—
—
0
0
16
182
0.87
0.15
1.6
1.4
—
—
—
0
0
9
78
1.16
0.15
12.8
7.1
0.9
1.3
%
—
9
78
9
78
1.16
0.15
12.9
7.1
0.9
0.7
%
—
9
78
15
131
1.15
0.14
1.7
1.5
—
—
—
0
0
36
334
1.09
0.14
1.6
1.5
—
—
—
0
0
7
90
0.77
0.14
1.0
1.2
—
—
—
0
0
16
141
1.14
0.14
1.9
2.4
—
—
—
0
0
58
551
1.07
0.14
1.8
1.6
1.2
1.3
mmol/l
0.57
51
474
13
114
1.15
0.12
2.5
1.3
—
—
—
0
0
80
774
1.05
0.10
3.3
2.5
—
—
—
0
0
6
72
0.83
0.07
1.0
1.7
—
—
—
0
0
189
1872
1.04
0.07
22.6
13.9
332.1
331.6
g/l
0.36
189
1859
26
249
1.05
0.04
1.3
1.3
—
—
—
0
0
12
114
1.06
0.01
1.3
1.8
—
—
—
0
0
6
63
0.95
0.00
4.3
5.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
3.8
—
56.6
—
0
6
0
6
0.00
0.00
0.0
1.7
—
138.7
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
17.8
—
0
5
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint L12_HAIRLOSS_NONSCARNAS and mortality.

Females

Parameter HR [95% CI] p-value
L12_HAIRLOSS_NONSCARNAS 1.264 [0.93, 1.72] 0.139
Birth year 0.996 [0.99, 1.0] 0.376

During the follow-up period (1.1.1998 — 31.12.2019), 54 out of 1161 females with L12_HAIRLOSS_NONSCARNAS died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_HAIRLOSS_NONSCARNAS.

N-year risk Females Males
1 0.148% No data
5 0.788% No data
10 1.975% No data
15 3.802% No data
20 6.515% No data

Relationships between endpoints

↥

Index endpoint: L12_HAIRLOSS_NONSCARNAS – Other and unspecified nonscarring hair loss

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data